Literature DB >> 17659708

Compound Danshen injection improves endotoxin-induced microcirculatory disturbance in rat mesentery.

Jing-Yan Han1, Yoshinori Horie, Soichiro Miura, Yasutada Akiba, Jun Guo, Dan Li, Jing-Yu Fan, Yu-Ying Liu, Bai-He Hu, Li-Hua An, Xin Chang, Man Xu, De-An Guo, Kai Sun, Ji-Ying Yang, Shu-Ping Fang, Ming-Ji Xian, Masahiro Kizaki, Hiroshi Nagata, Toshifumi Hibi.   

Abstract

AIM: To investigate the effect of compound Danshen injection on lipopolysaccharide (LPS)-induced rat mesenteric microcirculatory dysfunctions and the underlying possible mechanism by an inverted intravital microscope and high-speed video camera system.
METHODS: LPS was continuously infused through the jugular artery of male Wistar rats at the dose of 2 mg/kg per hour. Changes in mesenteric microcirculation, such as diameters of arterioles and venules, velocity of RBCs in venules, leukocyte rolling, adhesion and emigration, free radicals released from post-capillary venules, FITC-albumin leakage and mast cell degranulation, were observed through an inverted intravital microscope assisted with CCD camera and SIT camera. Meanwhile, the expression of adhesion molecules CD11b/CD18 and the production of free radical in neutrophils, and the expression of intercellular adhesion molecule 1 (ICAM-1) in human umbilical vein endothelial cells (HUVECs) were quantified by flow cytometry (FACS) in vitro.
RESULTS: The continuous infusion with LPS resulted in a number of responses in microcirculation, including a significant increase in the positive region of venule stained with Monastral blue B, rolling and adhesion of leukocytes, production of oxygen radical in venular wall, albumin efflux and enhanced mast cell degranulation in vivo, all of which, except for the leukocyte rolling, were attenuated by the treatment with compound Danshen injection. Experiments performed in vitro further revealed that the expression of CD11b/CD18 and the production of oxygen free radical in neutrophils, and the expression of ICAM-1 in HUVECs were increased by exposure to LPS, and they were attenuated by compound Danshen injection.
CONCLUSION: These results suggest that compound Danshen injection is an efficient drug with multi-targeting potential for improving the microcirculatory disturbance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659708      PMCID: PMC4146797          DOI: 10.3748/wjg.v13.i26.3581

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  46 in total

1.  Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.

Authors:  Sonia Varadaradjalou; Frédéric Féger; Nathalie Thieblemont; Nadine Ben Hamouda; Jean-Marie Pleau; Michel Dy; Michel Arock
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

Review 2.  Shape and shift changes related to the function of leukocyte integrins LFA-1 and Mac-1.

Authors:  N Hogg; B Leitinger
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

3.  Toll-like receptor 4-mediated activation of murine mast cells.

Authors:  J D McCurdy; T J Lin; J S Marshall
Journal:  J Leukoc Biol       Date:  2001-12       Impact factor: 4.962

4.  Rolipram inhibits leukocyte-endothelial cell interactions in vivo through P- and E-selectin downregulation.

Authors:  María-Jesús Sanz; Angeles Alvarez; Laura Piqueras; Miguel Cerdá; Andrew C Issekutz; Roy R Lobb; Julio Cortijo; Esteban J Morcillo
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

5.  Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways.

Authors:  H P Jersmann; C S Hii; J V Ferrante; A Ferrante
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Organism-specific neutrophil-endothelial cell interactions in response to Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus.

Authors:  Jessica G Moreland; Gail Bailey; William M Nauseef; Jerrold P Weiss
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

7.  Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan.

Authors:  Teruo Ikeda; Masayuki Funaba
Journal:  Immunol Lett       Date:  2003-07-03       Impact factor: 3.685

8.  Intercellular adhesion molecule-1 (ICAM-1) is expressed on human neutrophils and is essential for neutrophil adherence and aggregation.

Authors:  J H Wang; D M Sexton; H P Redmond; R W Watson; D T Croke; D Bouchier-Hayes
Journal:  Shock       Date:  1997-11       Impact factor: 3.454

9.  CD11b and intercellular adhesion molecule-1 are involved in pulmonary neutrophil recruitment in lipopolysaccharide-induced airway disease.

Authors:  Jessica G Moreland; Robert M Fuhrman; Jonathan A Pruessner; David A Schwartz
Journal:  Am J Respir Cell Mol Biol       Date:  2002-10       Impact factor: 6.914

10.  Arteriovenous shunting blood flow is intravitally observed in the stomach after thermal injury in rats.

Authors:  Masashi Yoshida; Go Wakabayashi; Hideki Ishikawa; Shigeyuki Kawachi; Minoru Tanabe; Yoshihide Otani; Motohide Shimazu; Tetsuro Kubota; Masaki Kitajima
Journal:  Keio J Med       Date:  2002-12
View more
  9 in total

1.  Total salvianolic acid improves ischemia-reperfusion-induced microcirculatory disturbance in rat mesentery.

Authors:  Ming-Xia Wang; Yu-Ying Liu; Bai-He Hu; Xiao-Hong Wei; Xin Chang; Kai Sun; Jing-Yu Fan; Fu-Long Liao; Chuan-She Wang; Jun Zheng; Jing-Yan Han
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Attenuating effect of pretreatment with Yiqifumai on lipopolysaccharide-induced intestine injury and survival rate in rat.

Authors:  Qing Yuan; Jing Wang; Qiu-Hong Fang; Yu-Ying Liu; Jing-Yu Fan; Shu-Wen Zhang; Ying-Min Ma
Journal:  J Inflamm (Lond)       Date:  2011-05-02       Impact factor: 4.981

3.  Salvianolic Acid B Ameliorates Lipopolysaccharide-Induced Albumin Leakage from Rat Mesenteric Venules through Src-Regulated Transcelluar Pathway and Paracellular Pathway.

Authors:  Chun-Shui Pan; Ying-Hua Liu; Yu-Ying Liu; Yu Zhang; Ke He; Xiao-Yuan Yang; Bai-He Hu; Xin Chang; Ming-Xia Wang; Xiao-Hong Wei; Jing-Yu Fan; Xin-Min Wu; Jing-Yan Han
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

4.  The stability investigation of compound Danshen injection (a traditional medicine) with a new high-performance liquid chromatography method.

Authors:  Yanqing Zhang; Fengqin Bao; Zhixia Zhao; Xiuyu Sun; Wuqin Qi; Junbo Xie
Journal:  Pharmacogn Mag       Date:  2013-10       Impact factor: 1.085

5.  Recommendations on the Clinical Use of Compound Danshen Dripping Pills.

Authors: 
Journal:  Chin Med J (Engl)       Date:  2017-04-20       Impact factor: 2.628

6.  Luteolin ameliorates lipopolysaccharide-induced microcirculatory disturbance through inhibiting leukocyte adhesion in rat mesenteric venules.

Authors:  Jie Su; Han-Ting Xu; Jing-Jing Yu; Mei-Qiu Yan; Ting Wang; Ya-Jun Wu; Bo Li; Wen-Jie Lu; Chuan Wang; Shan-Shan Lei; Si-Min Chen; Su-Hong Chen; Gui-Yuan Lv
Journal:  BMC Complement Med Ther       Date:  2021-01-14

7.  Observation of mesenteric microcirculatory disturbance in rat by laser oblique scanning optical microscopy.

Authors:  Yichen Ding; Yu Zhang; Tong Peng; Yiqing Lu; Dayong Jin; Qiushi Ren; Yuying Liu; Jingyan Han; Peng Xi
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

8.  High-molecular-weight hyaluronan--a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats.

Authors:  Yung-Yang Liu; Cheng-Hung Lee; Rejmon Dedaj; Hang Zhao; Hicham Mrabat; Aviva Sheidlin; Olga Syrkina; Pei-Ming Huang; Hari G Garg; Charles A Hales; Deborah A Quinn
Journal:  Crit Care       Date:  2008-08-08       Impact factor: 9.097

9.  Pharmacokinetic study of salvianolic acid D after oral and intravenous administration in rats.

Authors:  Junke Song; Wen Zhang; Jialin Sun; Xiaona Xu; Xue Zhang; Li Zhang; Zhangying Feng; Guan-Hua Du
Journal:  Acta Pharm Sin B       Date:  2015-04-27       Impact factor: 11.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.